Publishing research using ab8251? Please let us know so that we can cite the reference in this datasheet.
ab8251 has been referenced in 5 publications.
Hassan F et al.Adenovirus-Mediated Delivery of Decoy Hyper Binding Sites Targeting Oncogenic HMGA1 Reduces Pancreatic and Liver Cancer Cell Viability.Mol Ther Oncolytics 8:52-61 (2018).
Garcia-Carbonero R et al.Phase 1 study of intravenous administration of the chimeric adenovirus enadenotucirev in patients undergoing primary tumor resection.J Immunother Cancer 5:71 (2017).
Pang T et al.Fiber-modified hexon-chimeric oncolytic adenovirus targeting cancer associated fibroblasts inhibits tumor growth in gastric carcinoma.Oncotarget 8:76468-76478 (2017).
Yilmazer A et al.Development of dual-activity vectors by co-envelopment of adenovirus and SiRNA in artificial lipid bilayers.PLoS One 9:e114985 (2014).
Van den Bossche J et al.Intracellular trafficking and gene expression of pH-sensitive, artificially enveloped adenoviruses in vitro and in vivo.Biomaterials 32:3085-93 (2011).
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Get resources and offers direct to your inboxSign up